OTC Triptans - Venezuela

August 2009 | 28 pages | ID: O47341D746EEN
Euromonitor International Ltd

Abstracts

OTC triptans were not available in the Venezuelan market and it is unlikely that they will be introduced as OTC in the future.

Euromonitor International's OTC triptans in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2004-2008, allowing you to identify the sectors driving growth. Forecasts to 2013 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the OTC triptans market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

OTC Triptans in Venezuela
Euromonitor International
August 2009

LIST OF CONTENTS AND TABLES

Executive Summary
Growth Continues for OTC Healthcare in 2008
Innovation Scarce in Unfavourable Economic Climate
Boehringer Ingelheim Leads But Faces Strong Competition
Parapharmacies/drugstores Remains the Leading Distribution Channel in 2008
Moderate Growth Predicted for the Forecast Period
Key Trends and Developments
Economic Climate Limits Launches and Innovations
Health and Wellness Trend Becomes Stronger Among Venezuelans
Oil Revenues and Social Programmes Support Consumption Growth
Consumers Opt for Brands in the Context of A Positive Economic Performance
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  Table 2 Life Expectancy at Birth 2003-2008
Market Data
  Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  Table 5 OTC Healthcare Company Shares by Value 2004-2008
  Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
National Legislation
Advertising
Retail Distribution
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Definitions
  Summary 1 Research Sources
Calox International Ca
Strategic Direction
Key Facts
  Summary 2 Calox International CA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 3 Calox International CA: Competitive Position 2008
Konsuma De Venezuela SA
Strategic Direction
Key Facts
  Summary 4 Konsuma de Venezuela SA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 5 Konsuma de Venezuela SA: Competitive Position 2008
Laboratorios Elmor SA
Strategic Direction
Key Facts
  Summary 6 Laboratorios Elmor SA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 7 Laboratorios Elmor SA: Competitive Position 2008
Laboratorios Genven SA
Strategic Direction
Key Facts
  Summary 8 Laboratorios Genven SA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 9 Laboratorios Genven SA: Competitive Position 2008
Vargas Ca
Strategic Direction
Key Facts
  Summary 10 Vargas CA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 11 Vargas CA: Competitive Position 2008
Trends